Phase 2 Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older (both men and women)
- People who have been diagnosed with Parkinson's disease using a specific set of recognised diagnostic standards (known as UKPDSBB criteria)
- People with mild to moderate Parkinson's disease, based on a standard rating scale called the Hoehn and Yahr Scale (scores 1 to 3)
- People who either self-report anxiety or have received a clinical diagnosis of anxiety
- People who have signed a consent form agreeing to take part in the study
Who may not be able to join:
- Women who are pregnant or breastfeeding
- People whose Parkinson's disease was diagnosed less than one year ago
- People whose Parkinson's disease medication has changed or been unstable in the last two weeks
- People with Parkinson's disease who have a deep brain stimulation (DBS) device
- People who have another neurological degenerative condition, such as multiple system atrophy or Huntington's disease
- People who have been diagnosed with major depressive disorder
- People who have used certain medications — including SSRIs, SNRIs, benzodiazepines, or beta-blockers — in the last four weeks
- People who have a history of using MAO inhibitor medications
- People who have a history of alcohol or substance abuse
- People who have experienced acute (sudden or severe) stress in the last three months
- People who have a history of suicide
- People who have a history of cardiovascular (heart or blood vessel) disease
- People who have a history of liver or kidney disorders
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Leila Dargahi, PharmD/PhD, Shahid Beheshti University of Medical Sciences
Phone: +989125069930
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Anxiety score; Anxiety score
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.